Cargando…
Simvastatin Is Effective in Killing the Radioresistant Breast Carcinoma Cells
BACKGROUND: Statins, small molecular 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors, are widely used to lower cholesterol levels in lipid-metabolism disorders. Recent preclinical and clinical studies have shown that statins exert beneficial effects in the management of breast cancer by i...
Autores principales: | Aschenbrenner, Bertram, Negro, Giulia, Savic, Dragana, Sorokin, Maxim, Buzdin, Anton, Ganswindt, Ute, Cemazar, Maja, Sersa, Gregor, Skvortsov, Sergej, Skvortsova, Ira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sciendo
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366725/ https://www.ncbi.nlm.nih.gov/pubmed/33939900 http://dx.doi.org/10.2478/raon-2021-0020 |
Ejemplares similares
-
Molecular Heterogeneity in Breast Carcinoma Cells with Increased Invasive Capacities
por: Negro, Giulia, et al.
Publicado: (2020) -
Erk1/2-Dependent HNSCC Cell Susceptibility to Erastin-Induced Ferroptosis
por: Savic, Dragana, et al.
Publicado: (2023) -
Therapy resistance mediated by exosomes
por: Steinbichler, Teresa Bernadette, et al.
Publicado: (2019) -
Electrochemotherapy of radioresistant head and neck squamous cell carcinoma cells and tumor xenografts
por: Zakelj, Martina Niksic, et al.
Publicado: (2019) -
Transcriptome-Based Traits of Radioresistant Sublines of Non-Small Cell Lung Cancer Cells
por: Pustovalova, Margarita, et al.
Publicado: (2023)